Effect of immunosuppressive drugs on alpha interferon production by lymphomonocytes from transplanted patients

G. Lorino,M. T. Lun,P. Filadoro,C. Mancinl,M. R. Capobianchi,P. Di Marco,F. Dianzani,D. Allani,R. Cortasini
DOI: https://doi.org/10.1111/j.1399-0012.1988.tb00160.x
1988-10-01
Clinical Transplantation
Abstract:The interferons system is an important defense mechanism of human body; its functional integrity is essential in high‐risk patients such as transplant recipients treated with immunosuppressive therapy. Our study aimed at evaluating the capacity of PBMC from transplant patients undergoing cyclosporine A or conventional therapy to respond to several interferon inducers: killed mycoplasma pneumoniae, able to induce alpha interferon production in PBMC from healthy donors: Newcastle disease virus for alpha interferon induction; staphylococcal enterotoxin B for gamma interferon induction. The results show that PBMC from kidney transplant patients treated with conventional therapy and stimulated with mycoplasma pneumoniae fail to produce alpha interferon. Moreover, with cyclosporine therapy alpha interferon production was markedly depressed at high doses of drug, but increased to control levels with maintenance doses. The same result was observed for gamma interferon with staphylococcal enterotoxin B. On the other hand, no difference in alpha interferon production was found in PBMC from patients in immunosuppressive therapy and from healthy donors stimulated by Newcastle disease virus. Data obtained from experiments adding in vitro cyclosporine A, showed inhibition of interferon production related only with staphylococcal cntcrotoxin B induction.
surgery,transplantation
What problem does this paper attempt to address?